Literature DB >> 31597449

Extracellular MicroRNA-92a Mediates Endothelial Cell-Macrophage Communication.

Ya-Ju Chang1, Yi-Shuan Li1, Chia-Ching Wu2,3, Kuei-Chun Wang1, Tzu-Chieh Huang3, Zhen Chen4, Shu Chien1.   

Abstract

OBJECTIVE: Understanding message delivery among vascular cells is essential for deciphering the intercellular communications in cardiovascular diseases. MicroRNA (miR)-92a is enriched in endothelial cells (ECs) and circulation under atheroprone conditions. Macrophages are the primary immune cells in atherosclerotic lesions that modulate lesion development. Therefore, we hypothesize that, in response to atheroprone stimuli, ECs export miR-92a to macrophages to regulate their functions and enhance atherosclerotic progression. Approach and
Results: We investigated the macrophage functions that are regulated by EC miR-92a under atheroprone microenvironments. We first determined the distributions of functional extracellular miR-92a by fractionating the intravesicular and extravesicular compartments from endothelial conditioned media and mice serum. The results indicate that extracellular vesicles are the primary vehicles for EC miR-92a transportation. Overexpression of miR-92a in ECs enhanced the proinflammatory responses and low-density lipoprotein uptake, while impaired the migration, of cocultured macrophage. Opposite effects were found in macrophages cocultured with ECs with miR-92a knockdown. Further analyses demonstrated that intravesicular miR-92a suppressed the expression of target gene KLF4 (Krüppel-like factor 4) in macrophages, suggesting a mechanism by which intravesicular miR-92a regulates recipient cell functions. Indeed, the overexpression of KLF4 rescued the EC miR-92a-induced macrophage atheroprone phenotypes. Furthermore, an inverse correlation of intravesicular miR-92a in blood serum and KLF4 expression in lesions was observed in atherosclerotic animals, indicating the potential function of extracellular miR-92a in regulating vascular diseases.
CONCLUSIONS: EC miR-92a can be transported to macrophages through extracellular vesicles to regulate KLF4 levels, thus leading to the atheroprone phenotypes of macrophage and, hence, atherosclerotic lesion formation.

Entities:  

Keywords:  atherosclerosis; endothelial cells; extracellular vesicles; macrophages; microRNA

Mesh:

Substances:

Year:  2019        PMID: 31597449      PMCID: PMC6879873          DOI: 10.1161/ATVBAHA.119.312707

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  41 in total

1.  A KLF4-miRNA-206 autoregulatory feedback loop can promote or inhibit protein translation depending upon cell context.

Authors:  Chen-Chung Lin; Ling-Zhi Liu; Joseph B Addison; William F Wonderlin; Alexey V Ivanov; J Michael Ruppert
Journal:  Mol Cell Biol       Date:  2011-04-25       Impact factor: 4.272

2.  Modulation of macrophage phenotype by cell shape.

Authors:  Frances Y McWhorter; Tingting Wang; Phoebe Nguyen; Thanh Chung; Wendy F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

Review 3.  Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?

Authors:  Stephan Fichtlscherer; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

4.  Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium.

Authors:  Yun Fang; Peter F Davies
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-01-19       Impact factor: 8.311

Review 5.  Monocyte recruitment during infection and inflammation.

Authors:  Chao Shi; Eric G Pamer
Journal:  Nat Rev Immunol       Date:  2011-10-10       Impact factor: 53.106

6.  Atherosclerotic Conditions Promote the Packaging of Functional MicroRNA-92a-3p Into Endothelial Microvesicles.

Authors:  Yangyang Liu; Qian Li; Mohammed Rabiul Hosen; Andreas Zietzer; Anna Flender; Paula Levermann; Theresa Schmitz; Daniel Frühwald; Philip Goody; Georg Nickenig; Nikos Werner; Felix Jansen
Journal:  Circ Res       Date:  2019-02-15       Impact factor: 17.367

7.  Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice.

Authors:  Xavier Loyer; Stéphane Potteaux; Anne-Clémence Vion; Coralie L Guérin; Sheerazed Boulkroun; Pierre-Emmanuel Rautou; Bhama Ramkhelawon; Bruno Esposito; Marion Dalloz; Jean-Louis Paul; Pierre Julia; Jean Maccario; Chantal M Boulanger; Ziad Mallat; Alain Tedgui
Journal:  Circ Res       Date:  2013-11-19       Impact factor: 17.367

8.  RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activity.

Authors:  Evangelos Pefanis; Jiguang Wang; Gerson Rothschild; Junghyun Lim; David Kazadi; Jianbo Sun; Alexander Federation; Jaime Chao; Oliver Elliott; Zhi-Ping Liu; Aris N Economides; James E Bradner; Raul Rabadan; Uttiya Basu
Journal:  Cell       Date:  2015-05-07       Impact factor: 41.582

Review 9.  Recent insights into the cellular biology of atherosclerosis.

Authors:  Ira Tabas; Guillermo García-Cardeña; Gary K Owens
Journal:  J Cell Biol       Date:  2015-04-13       Impact factor: 10.539

Review 10.  The M1 and M2 paradigm of macrophage activation: time for reassessment.

Authors:  Fernando O Martinez; Siamon Gordon
Journal:  F1000Prime Rep       Date:  2014-03-03
View more
  31 in total

1.  MicroRNA Extracellular Vesicle Stowaways in Cell-Cell Communication and Organ Crosstalk.

Authors:  Maximillian A Rogers; Elena Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-11-26       Impact factor: 8.311

2.  METTL3-dependent N6-methyladenosine RNA modification mediates the atherogenic inflammatory cascades in vascular endothelium.

Authors:  Chian-Shiu Chien; Julie Yi-Shuan Li; Yueh Chien; Mong-Lien Wang; Aliaksandr A Yarmishyn; Ping-Hsing Tsai; Chi-Chang Juan; Phu Nguyen; Hao-Min Cheng; Teh-Ia Huo; Shih-Hwa Chiou; Shu Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

Review 3.  Vascular Endothelial Cells and Innate Immunity.

Authors:  Ying Shao; Jason Saredy; William Y Yang; Yu Sun; Yifan Lu; Fatma Saaoud; Charles Drummer; Candice Johnson; Keman Xu; Xiaohua Jiang; Hong Wang; Xiaofeng Yang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-05-27       Impact factor: 8.311

Review 4.  Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials.

Authors:  Yuncong Shi; Huanji Zhang; Suli Huang; Li Yin; Feng Wang; Pei Luo; Hui Huang
Journal:  Signal Transduct Target Ther       Date:  2022-06-25

5.  Circulating miRNA Fingerprint and Endothelial Function in Myocardial Infarction: Comparison at Acute Event and One-Year Follow-Up.

Authors:  Ana Mompeón; Daniel Pérez-Cremades; Ana Belén Paes; Juan Sanchis; Luis Ortega-Paz; Rut Andrea; Salvatore Brugaletta; Manel Sabate; Susana Novella; Ana Paula Dantas; Carlos Hermenegildo
Journal:  Cells       Date:  2022-06-02       Impact factor: 7.666

Review 6.  The Role of Extracellular Non-coding RNAs in Atherosclerosis.

Authors:  Yuting Cui; Yating Zhou; Ni Gan; Qiong Xiang; Mengdie Xia; Wei Liao; Xi-Long Zheng; Juan Peng; Zhihan Tang
Journal:  J Cardiovasc Transl Res       Date:  2022-03-01       Impact factor: 3.216

Review 7.  Emerging Roles of Extracellular Non-Coding RNAs in Vascular Diseases.

Authors:  Yaxiong Fang; Xiaoyan Dai
Journal:  J Cardiovasc Transl Res       Date:  2022-04-22       Impact factor: 3.216

8.  Reduction in MicroRNA-4488 Expression Induces NFκB Translocation in Venous Endothelial Cells Under Arterial Flow.

Authors:  Shao-Yu Fang; Chia-Wei Huang; Tzu-Chieh Huang; Anjali Yadav; Jeng-Jiann Chiu; Chia-Ching Wu
Journal:  Cardiovasc Drugs Ther       Date:  2021-02       Impact factor: 3.727

Review 9.  Macrophage Biology in Cardiovascular Diseases.

Authors:  Mitri K Khoury; Huan Yang; Bo Liu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-15       Impact factor: 8.311

Review 10.  The role of extracellular vesicles in regulating local and systemic inflammation in cardiovascular disease.

Authors:  Lee Ohayon; Xinyi Zhang; Partha Dutta
Journal:  Pharmacol Res       Date:  2021-06-25       Impact factor: 10.334

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.